Navigation Links
Two Drugs Better Than One for Crohn's Patients
Date:6/3/2009

t groups, the percentage of patients who developed serious infections was similar in all groups, and during the study extension there were no new opportunistic infections, malignancies or deaths.

"Results of this study will provide practitioners and their patients with more clinical data on how to use these drugs most appropriately to most effectively treat Crohn's disease," study author Dr. William J. Sandborn, vice chair of the division of gastroenterology and hepatology at the Mayo Clinic in Rochester, said in the news release. "For the first time, we have longer-term outcome data on the advantages of combination therapy that will help guide our treatment of patients with Crohn's disease."

Monoclonal antibodies, such as infliximab, are increasingly used to treat several types of gastroenterological disorders.

"The use of monoclonal antibodies is rising for a number of gastroenterological disorders, such as inflammatory bowel disease," said Dr. Nicholas J. Shaheen, of the University of North Carolina School of Medicine, in the news release. "New indications for these treatments are continuing to be developed and the safety profile is better understood, making them good treatment options for patients with recurrent or chronic gastrointestinal diseases."

This study is the first to provide longer term data on the benefits of combination infliximab-azathioprine and infliximab therapy. In the study, patients were started on the drugs earlier in the course of the disease than typically occurs, Sanborn noted.

More information

For more on Crohn's disease, visit the National Digestive Diseases Information Clearinghouse.



-- Jennifer Thomas



SOURCE: Digestive Disease Week, news release, June 2, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. China Nepstar Chain Drugstore Appoints Chief Operating Officer
2. Mylans Chief Operating Officer Heather Bresch to Testify Before Congress Concerning Patent Settlements Between Brand and Generic Pharmaceutical Companies and Tactics That Delay Market Entry of High Quality, Affordable Generic Drugs
3. drugstore.com, inc. to Present at Upcoming Financial Conferences
4. Isis Highlights New Clinical Data on Anti-Cancer Antisense Drugs Featured at ASCO
5. Two Drugs Safe for Rare Forms of Kidney Cancer
6. Marijuana rivals mainstream drugs for HIV/AIDS symptoms
7. Dementia drugs may put some patients at risk, Queens study shows
8. In the Case of Epilepsy, Generic Drugs and Random Product Substitution are Not Always "Good Medicine"
9. China Nepstar Chain Drugstore Reports First Quarter 2009 Financial Results
10. China Nepstar Chain Drugstore Filed 2008 Annual Report on Form 20-F
11. Launch of Highly Anticipated Oral Agents and Increasing Use of Current and Emerging Injectable Drugs Will Drive the Multiple Sclerosis Drug Market to Nearly $10 Billion in 2018
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Two Drugs Better Than One for Crohn's Patients
(Date:5/23/2013)... (PRWEB) May 23, 2013 Click here ... Canadian tech start-ups are increasingly seeing their success develop ... larger US-based companies, according to new research carried ... , The company has compiled its research into ... The findings of the research have shown the general ...
(Date:5/23/2013)... Jeanne Ettelson, president of Beyond OCD ... only free OCD support group in Chicago. Launched ... sufferers, the group is lead by psychologists who specialize ... allows group participants to learn accurate information about OCD, ... “Participants in Beyond OCD’s support group benefit from ...
(Date:5/23/2013)... Cheap Concert Tickets announces that Paul McCartney will ... North America. This well known ticket website has slashed ... help McCartney fans see Sir Paul live in concert. ... is also offering the customer appreciation code SAVE for additional ... she is also a huge McCartney fan and plans to ...
(Date:5/23/2013)... Schools should ensure that kids get at least ... support their health and boost performance in school, ... previous studies show 60 minutes of vigorous to ... estimated that only about 50 percent of school-aged ... the report from the Institute of Medicine. ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- Symptoms of ... psychiatric disorders, complicating diagnosis and treatment. But researchers ... that may be unique to borderline personality disorder: ... face. , , "They have difficulty processing facial ... a neutral face," said Anthony Ruocco, a clinical ...
Breaking Medicine News(10 mins):Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 2Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 4Health News:Beyond OCD Support Group Marks Fifth Anniversary 2Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2Health News:U.S. School Kids Should Get Hour of Exercise Daily: Report 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 3
... states that post-menopausal women who cut their fat intake and ... grains tend to lose weight. // , ,The study ... gain and increasing of obesity rates. ,The results ... a low-fat diet without any weight-loss goals. In the first ...
... scientists reports that 'mad cow'-like diseases have not been a ... that are known to be associated with disease transmission.// ... Genome Research, Prof. Jaume Bertranpetit at the Universitat Pompeu Fabra ... to show that balancing selection associated with cannibalism has not ...
... Qiang at the National Health Conference has urged the health ... poor and needy instead of spending lot of funds on ... authorities not to be partial in offering health care to ... freezing funds for hospital expansion, infrastructure development as it is ...
... A recent study reported in the American Journal of ... of attempting suicide but rather decrease the suicide risk. ... antidepressant drugs should be closely monitored to find their ... cause adverse conditions. ,The researchers ...
... now that Vitamin D supplementation helps women but in a ... women could lead to long-lasting reduction in osteoporotic fractures in ... shown that children whose mothers were lacking in vitamin D ... ,It is a common sight and medical fact that Vitamin ...
... was always profiled as a disease of the Neurons ... finger on the participation// of Astrocytes in regulating blood ... and Alzheimer’s. ,According to Neuroscientist, Dr. Maiken ... path-breaking research signals the potential contribution of Astrocytes (Star ...
Cached Medicine News:Health News:New Study Questions Cannibalism As A Worldwide Selective Force 2
(Date:5/23/2013)... 2013  MedVantx, Inc., the company that has pioneered ... today the Company has completed a major expansion of ... products and the upgrade of its systems to offer ... its specialty home delivery pharmacy in Sioux ... manufacturers, physicians, health systems and payors novel distribution services, ...
(Date:5/23/2013)...  Echo Pharma Acquisition Limited ("Royalty Pharma") announced today ... Threshold from 90 percent to 50 percent of Maximum ... with the terms of the Revised Offer Document issued ... Under the terms of the Increased Offer, Royalty Pharma ... ) for $12.50 per share in cash. The Increased ...
(Date:5/23/2013)... May 23, 2013  PAREXEL International Corporation (NASDAQ: ... presenting at the Jefferies Healthcare Conference in New York.  ... and Chief Financial Officer, will be making a presentation ... on Monday, June 3, 2013. A live ... "Investors" section of PAREXEL,s website at www.PAREXEL.com ...
Breaking Medicine Technology:MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10PAREXEL International To Present At Jefferies Healthcare Conference 2
... 2011 Caliper Life Sciences, Inc. (NASDAQ: ... for life science companies, today announced that Kevin Hrusovsky, President ... BioConference Live event, which was held on October 26, and ... Forum on October 27 held at Harvard Medical School. ...
... Conn., Nov. 7, 2011 Boehringer Ingelheim Pharmaceuticals, Inc. ... a Phase 2b study, SOUND-C2, that showed the combination ... compounds – the protease inhibitor BI 201335 and the ... successful in reducing viral load below the lower limit ...
Cached Medicine Technology:Caliper CEO Kevin Hrusovsky Presented Vision for Revolutionizing Medicine 2Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 2Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 3Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 4Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 5
... The Macula Plus® 5.5 ... observation of the optic ... Use it with your ... detecting choroidal neovascular membranes, ...
... iQ200 Automated Urine Microscopy Analyzer (iQ200) ... (APR) software to classify urine particles ... results. The iQ200 eliminates most technologist ... particle images by automating specimen preparation, ...
... is based on the C6 peptide antigen, a ... VlsE. This peptide has been shown to ... all of the antigenic reactivity of the whole ... C6 peptide is a sensitive and specific marker ...
First to USA-market, this revolutionary technology combines CBC and CRP analysis for stat results of 17 parameters within 4.5 minutes!...
Medicine Products: